Has Jack Facundus received payments from drug or device companies?

Yes. Drug and device makers reported $4,672 in general payments to Jack Facundus across 52 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jack Facundus did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jack Facundus come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jack Facundus

Psychiatric/Mental Health · Longwood, FLNPI 1376092809

Payments from drug & device makers

$4,672in general payments, 2019–2025

Across 52 payments — averaging $89.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$401
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$367
AstraZeneca$353
Gilead$326
Teva Pharmaceuticals USA, Inc.$302
Grifols USA, LLC$252
plus $3K from 18 others

What the payments were for

Food & beverage$4,672100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	4	$401
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$367
AstraZeneca	3	$353
Gilead	3	$326
Teva Pharmaceuticals USA, Inc.	3	$302
Grifols USA, LLC	2	$252
Neurocrine Biosciences, Inc.	2	$249
E.r. Squibb & Sons, L.L.C.	2	$239
Paratek Pharmaceuticals, Inc.	2	$226
Amgen(2 entities)	2	$218
Biogen	2	$195
Sanofi	2	$191
Medtronic	1	$146
Johnson & Johnson	2	$140
Bard Access Systems, Inc.	10	$134
Vanda Pharmaceuticals Inc.	1	$125
Axsome Therapeutics, Inc.	1	$122
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$114
Genentech USA, Inc.	1	$114
Abiomed	1	$96
GSK	1	$92
Esperion Therapeutics, Inc.	1	$91
Bayer	1	$89
GRT US Holding, Inc.	1	$89

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,672 in reported general payments places this provider in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sertraline Hcl	11	$16

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Longwood

Gabriel AlvarezLongwood$37K
Roger RiveraKissimmee$1.6M
Bethanie Simmons BecilJacksonville$782K
Hannah PhillipsMaitland$455K
Cheedy JajaTampa$266K
Scott DurrancePensacola$224K
Eudaldo AponteHialeah$214K
Heather WarrenTallahassee$172K
Angela DavenportAlachua$83K
Natalie MoodyWinter Haven$75K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →